BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10828889)

  • 1. Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.
    Duriez C; Falette N; Cortes U; Moyret-Lalle C; Puisieux A
    Oncogene; 2000 May; 19(20):2461-4. PubMed ID: 10828889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the KAI1 metastasis suppressor gene a cellular target of p53? A review of current evidence.
    Jackson P; Puisieux A
    Biochem Biophys Res Commun; 2000 Nov; 278(3):499-502. PubMed ID: 11095940
    [No Abstract]   [Full Text] [Related]  

  • 3. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
    Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
    Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
    Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic organization of the human KAI1 metastasis-suppressor gene.
    Dong JT; Isaacs WB; Barrett JC; Isaacs JT
    Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene.
    Gao AC; Lou W; Dong JT; Barrett JC; Danielpour D; Isaacs JT
    Prostate; 2003 Dec; 57(4):256-60. PubMed ID: 14601021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
    Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
    Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
    Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
    Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
    Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M; Birner P; Breitenecker G; Oberhuber G
    Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 tetraspanin and metastasis suppressor.
    Jackson P; Marreiros A; Russell PJ
    Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.